Search research articles
Contact Us
Filters
Showing results (241-250 of 265) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Matthew P Goetz, Krishna R Kalari, Vera J Suman, et al.
Breast Cancer Research and Treatment
|
August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
Marissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Breast Cancer Research and Treatment
|
August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Lauren Lenz, Chris Neff, Cara Solimeno, et al.
JAMA Oncology
|
October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial
Joseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute
|
September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Kathy S Albain, Robert J Gray, Della F Makower, et al.
JAMA
|
April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Roberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
NCCN Guidelines Insights: Breast Cancer, Version 1.2017
William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
The New England Journal of Medicine
|
June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 8, 2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Benjamin O Anderson, Jame Abraham, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 265) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Matthew P Goetz, Krishna R Kalari, Vera J Suman, et al.
Breast Cancer Research and Treatment
|
August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
Marissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Breast Cancer Research and Treatment
|
August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Lauren Lenz, Chris Neff, Cara Solimeno, et al.
JAMA Oncology
|
October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial
Joseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute
|
September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Kathy S Albain, Robert J Gray, Della F Makower, et al.
JAMA
|
April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Roberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
NCCN Guidelines Insights: Breast Cancer, Version 1.2017
William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
The New England Journal of Medicine
|
June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 8, 2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Benjamin O Anderson, Jame Abraham, et al.
Page
of 27